CD28 and stage 5 chronic kidney disease: End-stage renal disease (ESRD) and solid organ transplants have both been associated with an increase of CD28- T cells (and therefore a decrease of CD28+ T cells) (40) which could account for the loss of CD28+ T cells in our data.